BETHESDA, Md.--(BUSINESS WIRE)--Care Progress, LLC announced today that it was awarded a Phase II Small Business Innovation Research (“SBIR”) grant from the National Science Foundation (“NSF”). The Phase II award will fund the further development of the company’s CarePrompter© software platform, which improves outcomes for cancer patients as well as workflow and profitability for oncology departments and practices.
"This Phase II SBIR award is a significant milestone for us," said Howard Isenstein, Founder of Care Progress. "It provides support for further development of our critical technology. With this award, we will accelerate our plans to develop additional functionality for cancer providers and patients within a large and growing market."
The Phase II SBIR award will support a detailed development program, including product design, production and testing, that will be performed in collaboration with world class oncologists across the country at Georgetown University Lombardi Comprehensive Cancer Center, Inova Health, Hackensack University Medical Center, Rush University Medical Center and Christus Health.
Inadequately managed treatment side effects result in millions of preventable emergency and inpatient admissions every year. CarePrompter aims to drastically reduce them by enabling oncology departments to effectively and efficiently help cancer patients manage their symptoms.
This is the second NSF SBIR grant awarded to Care Progress. In collaboration with Georgetown University Lombardi Comprehensive Cancer Center, Care Progress successfully developed and tested its beta version of CarePrompter.
About Care Progress
Care Progress, LLC develops innovative technology to improve patient outcomes, practice profitability and workflow. Further information is available at www.careprogress.com. The content is solely the responsibility of Care Progress and does not necessarily represent the official views of its partners or the National Science Foundation.